UK Dysmenorrhea Treatment Market

ID: MRFR/HC/51117-HCR
200 Pages
Rahul Gotadki
Last Updated: July 15, 2026
UK Dysmenorrhea Treatment Market Research Report: Size, Share, Trend Analysis By Product Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), By Types of Treatment (Pain Relievers, Hormonal Therapy, Surgery) and By End-User (Hospitals and amp; Clinics, Research Centers) - Growth Outlook & Industry Forecast 2025 To 2035
UK Dysmenorrhea Treatment Market
Market Size
Forecast Period2025-2035
CAGR (2025-2035)15.53%
2023 Market Size$ 170.1 Million
2024 Market Size$ 170.1 Million
2035 Market Size$ 832.6 Million
Key Players
GlaxoSmithKline
Teva Pharmaceutical
HoffmannLa Roche
BristolMyers Squibb
Amgen
Pfizer
Opportunities
  • Digital Healthcare and Rising Women's Health Awareness
  • Growing Adoption of Personalized and Hormone-Based Therapies
  1. EXECUTIVE SUMMARY
    1. Market Overview
    2. Key Findings
    3. Market Segmentation
    4. Competitive Landscape
    5. Challenges and Opportunities
    6. Future Outlook
  2. MARKET INTRODUCTION
    1. Definition
    2. Scope of the study
    3. Research Objective
    4. Assumption
    5. Limitations
  3. RESEARCH METHODOLOGY
    1. Overview
    2. Data Mining
    3. Secondary Research
    4. Primary Research
    5. Primary Interviews and Information Gathering Process
    6. Breakdown of Primary Respondents
    7. Forecasting Model
    8. Market Size Estimation
    9. Bottom-Up Approach
    10. Top-Down Approach
    11. Data Triangulation
    12. Validation
  4. MARKET DYNAMICS
    1. Overview
    2. Drivers
    3. Restraints
    4. Opportunities
  5. MARKET FACTOR ANALYSIS
    1. Value chain Analysis
    2. Porter's Five Forces Analysis
    3. Bargaining Power of Suppliers
    4. Bargaining Power of Buyers
    5. Threat of New Entrants
    6. Threat of Substitutes
    7. Intensity of Rivalry
    8. COVID-19 Impact Analysis
    9. Market Impact Analysis
    10. Regional Impact
    11. Opportunity and Threat Analysis
  6. UK UK Dysmenorrhea Treatment Market, BY Product Type (USD Million)
    1. Primary Dysmenorrhea
    2. Secondary Dysmenorrhea
  7. UK UK Dysmenorrhea Treatment Market, BY Type of Treatment (USD Million)
    1. Pain Relievers
    2. Hormonal Therapy
    3. Surgery
  8. UK UK Dysmenorrhea Treatment Market, BY End-User (USD Million)
    1. Hospitals & Clinics
    2. Research Centers
    3. Competitive Landscape
    4. Overview
    5. Competitive Analysis
    6. Market share Analysis
    7. Major Growth Strategy in the Dysmenorrhea Treatment Market
    8. Competitive Benchmarking
    9. Leading Players in Terms of Number of Developments in the Dysmenorrhea Treatment Market
    10. Key developments and growth strategies
    11. New Product Launch/Service Deployment
    12. Merger & Acquisitions
    13. Joint Ventures
    14. Major Players Financial Matrix
    15. Sales and Operating Income
    16. Major Players R&D Expenditure. 2023
    17. Company Profiles
    18. GlaxoSmithKline
    19. Financial Overview
    20. Products Offered
    21. Key Developments
    22. SWOT Analysis
    23. Key Strategies
    24. Teva Pharmaceutical
    25. Financial Overview
    26. Products Offered
    27. Key Developments
    28. SWOT Analysis
    29. Key Strategies
    30. HoffmannLa Roche
    31. Financial Overview
    32. Products Offered
    33. Key Developments
    34. SWOT Analysis
    35. Key Strategies
    36. BristolMyers Squibb
    37. Financial Overview
    38. Products Offered
    39. Key Developments
    40. SWOT Analysis
    41. Key Strategies
    42. Amgen
    43. Financial Overview
    44. Products Offered
    45. Key Developments
    46. SWOT Analysis
    47. Key Strategies
    48. Pfizer
    49. Financial Overview
    50. Products Offered
    51. Key Developments
    52. SWOT Analysis
    53. Key Strategies
    54. Bayer
    55. Financial Overview
    56. Products Offered
    57. Key Developments
    58. SWOT Analysis
    59. Key Strategies
    60. Johnson & Johnson
    61. Financial Overview
    62. Products Offered
    63. Key Developments
    64. SWOT Analysis
    65. Key Strategies
    66. Eli Lilly
    67. Financial Overview
    68. Products Offered
    69. Key Developments
    70. SWOT Analysis
    71. Key Strategies
    72. Merck & Co
    73. Financial Overview
    74. Products Offered
    75. Key Developments
    76. SWOT Analysis
    77. Key Strategies
    78. AstraZeneca
    79. Financial Overview
    80. Products Offered
    81. Key Developments
    82. SWOT Analysis
    83. Key Strategies
    84. AbbVie
    85. Financial Overview
    86. Products Offered
    87. Key Developments
    88. SWOT Analysis
    89. Key Strategies
    90. Sanofi
    91. Financial Overview
    92. Products Offered
    93. Key Developments
    94. SWOT Analysis
    95. Key Strategies
    96. Novartis
    97. Financial Overview
    98. Products Offered
    99. Key Developments
    100. SWOT Analysis
    101. Key Strategies
    102. Mylan N.V.
    103. Financial Overview
    104. Products Offered
    105. Key Developments
    106. SWOT Analysis
    107. Key Strategies
    108. Appendix
    109. References
    110. Related Reports
    111. LIST Of tables
  9. LIST OF ASSUMPTIONS
  10. UK Dysmenorrhea Treatment Market SIZE ESTIMATES & UK Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2019-2035 (USD Billions)
  11. UK Dysmenorrhea Treatment Market SIZE ESTIMATES & UK Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2019-2035 (USD Billions)
  12. UK Dysmenorrhea Treatment Market SIZE ESTIMATES & UK Dysmenorrhea Treatment Market, BY END-USER, 2019-2035 (USD Billions)
    1. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    2. ACQUISITION/PARTNERSHIP
    3. LIST Of figures
  13. MARKET SYNOPSIS
    1. UK DYSMENORRHEA TREATMENT MARKET ANALYSIS BY PRODUCT TYPE
    2. UK DYSMENORRHEA TREATMENT MARKET ANALYSIS BY TYPE OF TREATMENT
    3. UK DYSMENORRHEA TREATMENT MARKET ANALYSIS BY END-USER
  14. KEY BUYING CRITERIA OF DYSMENORRHEA TREATMENT MARKET
    1. RESEARCH PROCESS OF MRFR
  15. DRO ANALYSIS OF DYSMENORRHEA TREATMENT MARKET
    1. DRIVERS IMPACT ANALYSIS: DYSMENORRHEA TREATMENT MARKET
    2. RESTRAINTS IMPACT ANALYSIS: DYSMENORRHEA TREATMENT MARKET
    3. SUPPLY / VALUE CHAIN: DYSMENORRHEA TREATMENT MARKET
  16. DYSMENORRHEA UK Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2025 (% SHARE)
  17. DYSMENORRHEA UK Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2019 TO 2035 (USD Billions)
  18. DYSMENORRHEA UK Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2025 (% SHARE)
  19. DYSMENORRHEA UK Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2019 TO 2035 (USD Billions)
  20. DYSMENORRHEA UK Dysmenorrhea Treatment Market, BY END-USER, 2025 (% SHARE)
  21. DYSMENORRHEA UK Dysmenorrhea Treatment Market, BY END-USER, 2019 TO 2035 (USD Billions)
    1. BENCHMARKING OF MAJOR COMPETITORS

UK Dysmenorrhea Treatment Market Segmentation

 

  • UK Dysmenorrhea Treatment Market By Product Type (USD Million, 2019-2035)

    • Primary Dysmenorrhea
    • Secondary Dysmenorrhea

 

  • UK Dysmenorrhea Treatment Market By Type of Treatment (USD Million, 2019-2035)

    • Pain Relievers
    • Hormonal Therapy
    • Surgery

 

  • UK Dysmenorrhea Treatment Market By End-User (USD Million, 2019-2035)

    • Hospitals & Clinics
    • Research Centers

 

 

 

 

 

 

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.